上海cmc培訓(xùn) gmp and quality system in the us

上海cmc培訓(xùn) gmp and quality system in the us

ID:40121589

大?。?46.31 KB

頁數(shù):55頁

時間:2019-07-22

上海cmc培訓(xùn) gmp and quality system in the us_第1頁
上海cmc培訓(xùn) gmp and quality system in the us_第2頁
上海cmc培訓(xùn) gmp and quality system in the us_第3頁
上海cmc培訓(xùn) gmp and quality system in the us_第4頁
上海cmc培訓(xùn) gmp and quality system in the us_第5頁
資源描述:

《上海cmc培訓(xùn) gmp and quality system in the us》由會員上傳分享,免費在線閱讀,更多相關(guān)內(nèi)容在教育資源-天天文庫

1、GMPandQualitySystemintheUSJimLi,Ph.D.MBAJune29,20102PresentationOverview21CFRPart210and211美國藥品GMP法規(guī)ICHQ7AICH的原料藥指南CGMPprinciplesCGMP基本原則QualitysystemsbasedGMPapproach基于系統(tǒng)的GMP方法FDAcurrentconceptsonprocessvalidation目前FDA對工藝驗證方面的觀點美國藥品GMP法規(guī)21CFRPart210and211321CFRParts210and21121CFRParts210and211GMP

2、Regulationsforfinishedpharmaceuticals:美國藥品生產(chǎn)的GMP法規(guī)Establish“whatto”do,not“howto”法規(guī)建立了藥品生產(chǎn)規(guī)范的基本要求,但未闡明如何做MinimalstandardsMaximumflexibilitySpecificenoughtoaddressproblemsTechnologyneutralScalable4HistoryofCGMPRegulationCGMP法規(guī)的歷史和發(fā)展June1963firstissuedInterpretiveregulationBuildings,Equipment,Person

3、nel,Components,MasterandBatchRecordsProduction/ControlProcedures,ContainersandClosures,PackagingandLabeling,LaboratoryControls,DistributionRecords,Stability,CompliantFilesSept.1978majorrevisionBinding/substantiveregulationArticulatedinPart210SupportedbycaselawExpandedrequirementsWrittenprocedures

4、AutomationControlProcessValidationetcExtensivePreamble緒言Jan.1995,retrospectiveReviewRevisiontoallowflexibilitySeparateanddefinedareasonlyasnecessaryDegreeofcheckingcomputerI/OConditionallyexemptsINDsfromexpirationdatesClarifiesperiodicreviewrequirements5HistoryofCGMPRegulationCGMP法規(guī)的歷史和發(fā)展May1996P

5、roposedRevisionReflectscourtrulingin2/93BarrLabscaseUpdatesregulationstoreflectcurrentindustry:EmphasizeandclarifyprocessvalidationrequirementsClarifyrequirementsforinvestigatingout-of-specificationtestresultsEtc.NeverfinalizedandwithdrawnAug.2002CGMPInitiativeMajorgoalsFocusonpotentialriskstopub

6、lichealthEnsureenforcementdoesnotimpedeinnovationandintroductionofnewtechnologiesEnhanceconsistencyandpredictabilityofFDA’sapproachtoassuringqualityandsafety6Part210:CGMP,General通則210.1StatusofcurrentgoodmanufacturingpracticeregulationsMinimumCGMPrequirementsformethods,facilitiesorcontrols,manufa

7、cture,processing,packing,orholdingofadrugFailurerendersdrugadulterated偽劣HCT/Pssubjectto1271inadditiontoPart211210.2ApplicabilityofCGMPregulations.Parts211-226,600-680and1271consideredtosupplement,Applicabletotheoperati

當(dāng)前文檔最多預(yù)覽五頁,下載文檔查看全文

此文檔下載收益歸作者所有

當(dāng)前文檔最多預(yù)覽五頁,下載文檔查看全文
溫馨提示:
1. 部分包含數(shù)學(xué)公式或PPT動畫的文件,查看預(yù)覽時可能會顯示錯亂或異常,文件下載后無此問題,請放心下載。
2. 本文檔由用戶上傳,版權(quán)歸屬用戶,天天文庫負(fù)責(zé)整理代發(fā)布。如果您對本文檔版權(quán)有爭議請及時聯(lián)系客服。
3. 下載前請仔細(xì)閱讀文檔內(nèi)容,確認(rèn)文檔內(nèi)容符合您的需求后進行下載,若出現(xiàn)內(nèi)容與標(biāo)題不符可向本站投訴處理。
4. 下載文檔時可能由于網(wǎng)絡(luò)波動等原因無法下載或下載錯誤,付費完成后未能成功下載的用戶請聯(lián)系客服處理。